Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.21 | -4.74% | -0.06 |
MIRA closed down 9.64 percent on Wednesday, November 20, 2024, on 59 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | -4.74% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | -4.74% | |
200 DMA Support | Bullish | -4.74% | |
Wide Bands | Range Expansion | -4.74% | |
Down 3 Days in a Row | Weakness | -4.74% | |
Oversold Stochastic | Weakness | -4.74% | |
NR7 | Range Contraction | -13.93% | |
Narrow Range Bar | Range Contraction | -13.93% | |
Wide Bands | Range Expansion | -13.93% | |
Oversold Stochastic | Weakness | -13.93% |
Alert | Time |
---|---|
Down 5% | about 1 hour ago |
Down 3% | about 1 hour ago |
Up 5% | about 1 hour ago |
Up 3% | about 1 hour ago |
Fell Below 200 DMA | about 1 hour ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.01 |
52 Week Low | 0.51 |
Average Volume | 1,698,947 |
200-Day Moving Average | 1.23 |
50-Day Moving Average | 1.34 |
20-Day Moving Average | 1.63 |
10-Day Moving Average | 1.52 |
Average True Range | 0.21 |
RSI (14) | 40.48 |
ADX | 23.78 |
+DI | 19.08 |
-DI | 25.74 |
Chandelier Exit (Long, 3 ATRs) | 1.93 |
Chandelier Exit (Short, 3 ATRs) | 1.67 |
Upper Bollinger Bands | 2.18 |
Lower Bollinger Band | 1.09 |
Percent B (%b) | 0.16 |
BandWidth | 66.61 |
MACD Line | 0.01 |
MACD Signal Line | 0.07 |
MACD Histogram | -0.06 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.69 | ||||
Resistance 3 (R3) | 1.69 | 1.55 | 1.62 | ||
Resistance 2 (R2) | 1.55 | 1.44 | 1.55 | 1.59 | |
Resistance 1 (R1) | 1.41 | 1.38 | 1.34 | 1.41 | 1.57 |
Pivot Point | 1.27 | 1.27 | 1.23 | 1.27 | 1.27 |
Support 1 (S1) | 1.13 | 1.16 | 1.06 | 1.13 | 0.96 |
Support 2 (S2) | 0.99 | 1.10 | 0.99 | 0.94 | |
Support 3 (S3) | 0.85 | 0.99 | 0.92 | ||
Support 4 (S4) | 0.85 |